We are live on ! Find out more
DAM

Doheny Asset Management Portfolio holdings

AUM $153M
1-Year Est. Return 42.04%
This Fund
S&P 500
This Quarter Est. Return
-2.05%
1 Year Est. Return
+42.04%
3 Year Est. Return
+121.4%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$190M
AUM Growth
-$24.1M
Cap. Flow
-$16.3M
Cap. Flow %
-8.57%
Top 10 Hldgs %
38.37%
Holding
113
New
5
Increased
14
Reduced
53
Closed
10

Top Buys

Rank Stock Value
1
KPTI icon
Karyopharm Therapeutics
KPTI
+$3.04M
2
AIMT
Aimmune Therapeutics
AIMT
+$2.91M
3
KYNB
Kyntra Bio
KYNB
+$2.26M
4
HALO icon
Halozyme
HALO
+$1.07M
5
GILD icon
Gilead Sciences
GILD
+$895K

Top Sells

Rank Stock Value
1
WATT icon
Energous
WATT
+$4.26M
2
WFC icon
Wells Fargo
WFC
+$3.68M
3
EXAS
Exact Sciences
EXAS
+$2.35M
4
GLDD
Great Lakes Dredge & Dock
GLDD
+$1.8M
5
SRLP
SPRAGUE RESOURCES LP
SRLP
+$1.29M

Sector Composition

Rank Sector Weight
1 Technology 23.24%
2 Healthcare 15.3%
3 Financials 12.79%
4 Energy 12.07%
5 Real Estate 11.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CNI icon
76
Canadian National Railway
CNI
$76.9B
$424K 0.22%
5,800
– –
LOW icon
77
Lowe's Companies
LOW
$117B
$424K 0.22%
4,836
– –
OLED icon
78
Universal Display
OLED
$3.68B
$422K 0.22%
+4,175
New +$628K
APD icon
79
Air Products & Chemicals
APD
$65.7B
$392K 0.21%
2,467
– –
GS icon
80
Goldman Sachs
GS
$300B
$369K 0.19%
1,466
-700
-32% -$182K
EW icon
81
Edwards Lifesciences
EW
$49.6B
$349K 0.18%
7,515
-2,895
-28% -$126K
KO icon
82
Coca-Cola
KO
$377B
$345K 0.18%
7,955
-200
-2% -$8.98K
RESN
83
DELISTED
Resonant Inc.
RESN
$334K 0.18%
104,660
-10,775
-9% -$55.3K
KA
84
DELISTED
Kineta, Inc. Common Stock
KA
$331K 0.17%
+497
New +$300K
WAB icon
85
Wabtec
WAB
$49.1B
$326K 0.17%
4,000
– –
NOC icon
86
Northrop Grumman
NOC
$77.1B
$323K 0.17%
925
-1,850
-67% -$620K
SWK icon
87
Stanley Black & Decker
SWK
$14.3B
$316K 0.17%
2,064
– –
NKE icon
88
Nike
NKE
$61.9B
$311K 0.16%
4,675
– –
CAT icon
89
Caterpillar
CAT
$375B
$309K 0.16%
2,100
– –
EFX icon
90
Equifax
EFX
$20.3B
$295K 0.15%
2,500
– –
FATE icon
91
Fate Therapeutics
FATE
$286M
$288K 0.15%
29,490
+15,490
+111% +$148K
CALD
92
DELISTED
Callidus Software, Inc.
CALD
$270K 0.14%
7,500
-25,500
-77% -$871K
ENB icon
93
Enbridge
ENB
$119B
$266K 0.14%
8,462
– –
MIDD icon
94
Middleby
MIDD
$6.04B
$248K 0.13%
2,000
– –
BA icon
95
Boeing
BA
$171B
$247K 0.13%
+752
New +$254K
XLNX
96
DELISTED
Xilinx Inc
XLNX
$238K 0.12%
3,300
– –
SLB icon
97
SLB Ltd
SLB
$73.6B
$231K 0.12%
3,570
-1,050
-23% -$73.3K
PSA icon
98
Public Storage
PSA
$60.5B
$222K 0.12%
1,110
– –
LLY icon
99
Eli Lilly
LLY
$1.02T
$221K 0.12%
2,850
– –
MS icon
100
Morgan Stanley
MS
$331B
$210K 0.11%
3,894
– –
1 2 3
4
5

Similar funds

BVC
Bright Valley Capital Hong Kong $153M AUM 16.24% 1-Year Est. Return
BCI
Blue Capital Inc Omaha, Nebraska $153M AUM 28.69% 1-Year Est. Return
VFS
Valpey Financial Services Concord, New Hampshire $154M AUM 13.26% 1-Year Est. Return
MDP
Millbank Dartmoor Portsmouth Asheville, North Carolina $154M AUM
HPM
H. Partners Management New York $154M AUM 19.94% 1-Year Est. Return
APW
Atlantic Private Wealth Chapel Hill, North Carolina $153M AUM 15.75% 1-Year Est. Return
CCA
Cravens & Co Advisors Cookeville, Tennessee $154M AUM 17.67% 1-Year Est. Return
SOWAS
Silver Oak Wealth Advisors Services Los Angeles, California $154M AUM 13.96% 1-Year Est. Return

Doheny Asset Management's Q1 2018 Portfolio in Review

As of Q1 2018, Doheny Asset Management held 113 positions worth $190M, down 11% from $215M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Doheny Asset Management withdrew a net $16.3M in Q1 2018, closing 10 positions and reducing 53 holdings. Its most notable exit was Exact Sciences, an estimated $2.35M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 25% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Doheny Asset Management opened a new position in Karyopharm Therapeutics worth $3.07M.

  • Doheny Asset Management's largest Q1 2018 buy was Karyopharm Therapeutics: 15,266 shares worth $3.07M.
  • Doheny Asset Management added most to Kyntra Bio in Q1 2018, an estimated $2.26M increase.
  • Doheny Asset Management's biggest Q1 2018 reduction was Energous, cutting an estimated $4.26M.
  • Doheny Asset Management fully exited Exact Sciences in Q1 2018, selling an estimated $2.35M.
  • Doheny Asset Management's ten largest holdings make up 38% of its $190M portfolio in Q1 2018.
  • Doheny Asset Management opened 5 new positions and closed 10 in Q1 2018.
  • Doheny Asset Management's portfolio value fell 11% quarter-over-quarter to $190M.

Based on Doheny Asset Management's 13F filing for Q1 2018, filed 17 May 2018.